Polidais

Polidais is a Danish biotechnology company dedicated to the precision synthesis of complex polysaccharides for medical use. By employing a proprietary automated platform, the company overcomes the historical challenges of carbohydrate heterogeneity and difficult extraction processes. Their technology enables the creation of well-defined glycan structures that can serve as potent vaccine adjuvants or therapeutic components. Polidais is currently advancing its pipeline toward pre-clinical validation, with a primary focus on infectious diseases and oncology. The company is supported by the BioInnovation Institute and aims to revolutionize the field of glyco-medicine through standardized, high-purity synthetic glycans.